Herceptin binds to the HER2 receptors on the surface of cancer cells. This binding prevents the receptors from receiving growth signals, effectively halting the growth of the cells. Additionally, Herceptin can flag these cancer cells for destruction by the body's immune system, a process known as antibody-dependent cellular cytotoxicity (ADCC).
